1995
DOI: 10.1161/01.cir.91.9.2302
|View full text |Cite
|
Sign up to set email alerts
|

A De Novo Mutation in α-Tropomyosin That Causes Hypertrophic Cardiomyopathy

Abstract: De novo mutations in the alpha-tropomyosin gene can result in hypertrophic cardiomyopathy that may appear to be sporadic but in subsequent generations gives rise to familial disease. Individuals with sporadic hypertrophic cardiomyopathy should be advised of the risk of transmission to offspring. In addition, these findings provide the strongest genetic evidence that mutations in the alpha-tropomyosin gene are directly responsible for hypertrophic cardiomyopathy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
28
0
2

Year Published

1997
1997
2021
2021

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 56 publications
(30 citation statements)
references
References 16 publications
0
28
0
2
Order By: Relevance
“…Thus far, the abnormal genes identified in humans with FHC encode for mutations in sarcomeric proteins, such as ␣-and ␤-myosin heavy chain, ␣-tropomyosin, and cardiac troponin T (4,19,20). The clinical course of FHC is highly variable, with a spectrum at presentation that ranges from the asymptomatic carrier state to premature sudden death in childhood.…”
Section: Discussionmentioning
confidence: 99%
“…Thus far, the abnormal genes identified in humans with FHC encode for mutations in sarcomeric proteins, such as ␣-and ␤-myosin heavy chain, ␣-tropomyosin, and cardiac troponin T (4,19,20). The clinical course of FHC is highly variable, with a spectrum at presentation that ranges from the asymptomatic carrier state to premature sudden death in childhood.…”
Section: Discussionmentioning
confidence: 99%
“…[47][48][49][50][51] Because most mutations are unique for a family, many of the identified mutations have therefore not been described before. In certain countries and populations, however, founder mutations have been identified, arising from a common ancestor many generations ago.…”
mentioning
confidence: 99%
“…De novo mutation involving the α tropomyosin gene have been reported. They can result in transmission to descendants and can cause familial hypertrophic cardiomyopathy, as already referred to in relation to mutation Asp175Asn 64 . Carriers of apparently sporadic forms of mutation of this gene should be warned about the risk of transmission.…”
Section: Genetic Bases Of Hypertrophic Cardiomyopathy Updatementioning
confidence: 97%
“…Some of these mutations can interfere with calcium regulation in the thin filaments. Contrary to mutations of other genes, they are expressed in various structures like gametes, lymphocytes, and myocytes, but being only capable of producing myocardial disease 64 . Mutation Asp175Asn seems to predominate and produced a mutated protein expressed in the myocardium and skeletal musculature 65 .…”
Section: Genetic Bases Of Hypertrophic Cardiomyopathy Updatementioning
confidence: 99%